Abstract
Genetic instability often leads to tumourogenesis. Genomic alterations such as deletions of a chromosome region containing a tumour suppresser gene or amplification of a region containing an oncogene have been frequently found to be associated with the initiation and the progression of cancer. Therefore identification of chromosomal regions amplified or deleted in tumour cells may reveal the presence of such genes. Amplification of 20q13 for instance is frequently observed in breast cancer cells. This region contains a gene encoding a protein kinase that belongs to the Aurora/Ipl1p-related kinase family involved in microtubule dependent mitotic events that control chromosome segregation. Deregulation of these kinases perturbs the ploidy of the cells. The human genome encodes at least three different kinases that have been found to be overexpressed in different tumour cells. But only the ectopic overexpression of the kinase encoded by the gene located at 20q13 is capable to transform cultured cells an d induce the apparition of tumours in nude mouse. In this manuscript we describe the function of the three human Aurora/Ipl1p-related kinases, and review the genomic alterations reported for the chromosome region where the kinase genes localise. But we first discuss the impact of the human genome sequence project for the identification of new kinases in the context of cancer research.
Keywords: Aurora, Ipl1p Related Kinases, CDNA microarrays, Cellular apoptosis susceptibility, HsAIRK1, Xenopus laevis, HsAIRK2, HsAIRK3
Current Genomics
Title: Human Aurora / Ipl1p Related Kinases
Volume: 1 Issue: 3
Author(s): P. Sanseau, M. Bernard, Y. Arlot-Bonnemains and C Prigent
Affiliation:
Keywords: Aurora, Ipl1p Related Kinases, CDNA microarrays, Cellular apoptosis susceptibility, HsAIRK1, Xenopus laevis, HsAIRK2, HsAIRK3
Abstract: Genetic instability often leads to tumourogenesis. Genomic alterations such as deletions of a chromosome region containing a tumour suppresser gene or amplification of a region containing an oncogene have been frequently found to be associated with the initiation and the progression of cancer. Therefore identification of chromosomal regions amplified or deleted in tumour cells may reveal the presence of such genes. Amplification of 20q13 for instance is frequently observed in breast cancer cells. This region contains a gene encoding a protein kinase that belongs to the Aurora/Ipl1p-related kinase family involved in microtubule dependent mitotic events that control chromosome segregation. Deregulation of these kinases perturbs the ploidy of the cells. The human genome encodes at least three different kinases that have been found to be overexpressed in different tumour cells. But only the ectopic overexpression of the kinase encoded by the gene located at 20q13 is capable to transform cultured cells an d induce the apparition of tumours in nude mouse. In this manuscript we describe the function of the three human Aurora/Ipl1p-related kinases, and review the genomic alterations reported for the chromosome region where the kinase genes localise. But we first discuss the impact of the human genome sequence project for the identification of new kinases in the context of cancer research.
Export Options
About this article
Cite this article as:
Sanseau P., Bernard M., Arlot-Bonnemains Y. and Prigent C, Human Aurora / Ipl1p Related Kinases, Current Genomics 2000; 1 (3) . https://dx.doi.org/10.2174/1389202003351355
DOI https://dx.doi.org/10.2174/1389202003351355 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Adipose Tissue in the Regulation of Inflammation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Amplicons as Vaccine Vectors
Current Gene Therapy The De Novo Synthesis of Oligosaccharides: Application to the Medicinal Chemistry SAR-Study of Digitoxin
Current Topics in Medicinal Chemistry Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology Dual Roles of Sulforaphane in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Current Drug Metabolism Effects of the Novel Non-Peptidyl Low Molecular Weight Radical Scavenger IAC in Different Models of Inflammation: A New Perspective in Anti-Inflammatory Therapy
Current Medicinal Chemistry E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets A Sustainable Approach to Bis-Indole Synthesis Using Propylene Carbonate as an Eco-Friendly Solvent
Current Organic Synthesis A Comprehensive Study of Pharmacological Behaviors, Nano-Formulations, and Applications of Rosemary
The Natural Products Journal Lynch Syndrome: Awareness among Medical Students at a United States Medical School
Current Women`s Health Reviews Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of <i>Cannabis sativa</i> in Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Editorial [Hot Topic: Targeted Cancer Therapies: Current Status and Future Directions (Guest Editors: Ioannis Starakis)]
Current Medicinal Chemistry Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Current Pharmaceutical Design Lysophospholipids: Synthesis and Biological Aspects
Current Organic Chemistry Reversal of Multidrug Resistance by Natural Substances from Plants
Current Topics in Medicinal Chemistry A Systematic Review and Meta-Analysis about the Effect of Bisphosphonates on the Risk of Skeletal-Related Event in Men with Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives
Current Medicinal Chemistry Assessment and Classification of Mass Lesions Based on Expert Knowledge Using Mammographic Analysis
Current Medical Imaging